Explorative study on the predictive value of systematic inflammatory and metabolic markers on weight loss in head and neck cancer patients undergoing radiotherapy

Supportive Care in Cancer

Volumn 18, Issue 11, 2010, Pages 1385-1391

  Ehrsson, Ylva Tiblom ^a   Hellström, Per M ^b   Brismar, Kerstin ^a   Sharp, Lena ^c   Langius Eklöf, Ann ^d   Laurell, Göran ^e  

^a KAROLINSKA INSTITUTE   (Sweden)

^b UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^c KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^d ÖREBRO UNIVERSITY   (Sweden)

^e UMEÅ UNIVERSITY   (Sweden)

Author keywords

Albumin; Ghrelin; Highly sensitive C reactive protein; Insulin like growth factor 1; Insulin like growth factor binding protein 1; Weight loss

Indexed keywords

ALBUMIN; C REACTIVE PROTEIN; GHRELIN; SOMATOMEDIN BINDING PROTEIN 1; SOMATOMEDIN C; BIOLOGICAL MARKER;

ADULT; AGED; ALBUMIN BLOOD LEVEL; ARTICLE; BLOOD SAMPLING; C REACTIVE PROTEIN BLOOD LEVEL; CANCER PATIENT; CANCER RADIOTHERAPY; CLINICAL ARTICLE; DISEASE MARKER; EXPLORATORY RESEARCH; FEMALE; GHRELIN BLOOD LEVEL; HEAD AND NECK CANCER; HORMONE BLOOD LEVEL; HUMAN; HUMAN TISSUE; INFLAMMATION; MALE; MEASUREMENT; METABOLIC MARKER; ORAL MUCOSITIS; PREDICTION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SOMATOMEDIN BINDING PROTEIN 1 BLOOD LEVEL; SOMATOMEDIN C BLOOD LEVEL; SYSTEMIC DISEASE; TREATMENT RESPONSE; WEIGHT REDUCTION; HEAD AND NECK TUMOR; METABOLISM; MIDDLE AGED; PATHOLOGY; PREDICTIVE VALUE; RADIATION INJURY; STOMATITIS;

ADULT; AGED; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; INFLAMMATION; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; RADIATION INJURIES; STOMATITIS; WEIGHT LOSS;

EID: 79952118203     PISSN: 09414355     EISSN: 14337339     Source Type: Journal    
DOI: 10.1007/s00520-009-0758-4     Document Type: Article

References (27)

1. Trotti A, Bellm LA, Epstein JB, Frame D, Fuchs HJ, Gwede CK et al (2003) Mucositis incidence, severity and associated outcomes in patients with head and neck cancer receiving radiotherapy with or without chemotherapy: A systematic literature review. Radiother Oncol 66:253-262. doi:10.1016/S0167-8140(02)00404-8
2. Mangar S, Slevin N, Mais K, Sykes A (2006) Evaluating predictive factors for determining enteral nutrition in patients receiving radical radiotherapy for head and neck cancer: A retrospective review. Radiother Oncol 78:152-158. doi:10.1016/j.radonc.2005.12.014
3. Newman LA, Vieira F, Schwiezer V, Samant S, Murry T, Woodson G et al (1998) Eating and weight changes following chemoradiation therapy for advanced head and neck cancer. Arch Otolaryngol Head Neck Surg 124:589-592
4. Batty J (2000) Nutrition. In: Feber T (ed) Head and neck oncology nursing. Whurr, London, pp 171-188
5. Petruson K, Mercke C, Lundberg L-M, Silander E, Hammerlid E (2005) Longitudinal evaluation of patients with cancer in the oral tongue, tonsils, or base of tongue-does interstitial radiation dose affect quality of life? Brachytherapy 4:271-277. doi:10.1016/j. brachy.2005.06.001
6. Kubrak C, Olson K, Jha N, Jensen L, McCargar L, Seikaly H et al (2009) Nutrition impact symptoms: Key determinants of reduced dietary intake, weight loss, and reduced functional capacity of patients with head and neck cancer before treatment. Head Neck. doi:10.1002/hed.21174
7. Goodwin WJ, Byers PM (1993) Nutritional management of head and neck cancer patient. Med Clin North Am 77:597-610
8. Barber MD (2002) The pathopysiology and treatment of cancer cachexia. Nutr Clin Pract 17:203-209. doi:10.1177/ 0115426502017004203
9. Salas S, Deville JL, Giorgi R, Pignon T, Bagarry D, Barrau K et al (2008) Nutritional factors as predictors of response to radiochemotherapy and survival in unresectabel squamous head and neck carcinoma. Radiother Oncol 87:195-200. doi:10.1016/j. radonc.2008.02.011
10. García-Luna PP, Relimpio F, García de Pesquera F, Garrido M, Pereira JL, Gómez-Cía T et al (1994) Insulin-like growth factor I as a marker of nutritional status in patients on enteral nutrition. Nutr Hosp 9:36-43
11. Hilding A, Brismar K, Degerblad M, Thorén M, Hall K (1995) Altered relation between circulating levels of insulin-like growth factor-binding protein-l and insulin in growth hormone-deficient patients and insulin-dependent diabetic patients compared to that in healthy subjects. J Clin Endocrinol Metab 80:2646-2652
12. Levin F, Edholm T, Schmidt PT, Grybäck P, Jacobsson H, Degerblad M et al (2006) Ghrelin stimulates gastric emptying and hunger in normal-weight humans. J Clin Endocrinol Metab 91:3296-3302. doi:10.1210/jc.2005-2638
13. Peeters TL (2003) Central and peripheral mechanisms by which ghrelin regulates gut motility. J Physiol Pharmacol 54:95-103
14. Söderberg S, Ahrén B, Eliasson M, Dinesen B, Brismar K, Olsson T (2001) Circulating IGF binding protein-1 is inversely associated with leptin in non-obese men and obese postmenopausal women. Eur J Endocrinol 144:283-290
15. Póvoa G, Roovete A, Hall K (1984) Cross-reaction of serum somatomedin-binding protein in a radioimmunoassay developed for somatomedin-binding protein isolated from human amniotic fluid. Acta Endocrinol 107:563-570
16. Miller AB, Hoogstraten B, Staquet M, Winkler A (1981) Reporting results of cancer treatment. Cancer 47:207-214. doi:10.1002/1097-0142(19810101)47: 1<207::AID-CNCR2820470134>3.0.CO;2-6
17. Koc M, Taysi S, Sezen O, Bakan N (2003) Levels of some acutephase proteins in the serum of patients with cancer during radiotherapy. Biol Pharm Bull 26:1494-1497. doi:10.1248/ bpb.26.1494
18. Ki Y, Kim W, Nam J, Kim D, Park D, Kim D (2009) C-reactive protein levels and radiation-induced mucositis in patients with head-and-neck cancer. Int J Radiat Oncol Biol Phys 75:393-398. doi:10.1016/j.ijrobp.2008.11.012
19. Shimada H, Nabeya Y, Okazumi S-I, Matsubara H, Shiratori T, Aoki T et al (2003) Elevation of preoperative serum C-reactive protein level is related to poor prognosis in esophageal squamous cell carcinoma. J Surg Oncol 83:248-252. doi:10.1002/jso.10275
20. Guillem P, Triboulet JP (2005) Elevated serum levels of Creactive protein are indicative of a poor prognosis in patients with esophageal cancer. Dis Esophagus 18:146-150. doi:10.1111/ j.1442-2050.2005.00474.x
21. Gehring N, Imoberdorf R, Wegmann M, Rühlin M, Ballmer PE (2006) Serum albumin-a qualified parameter to determine the nutritional status? Swiss Med Wkly 136:664-669
22. Liu YL, Malik NM, Sanger GJ, Andrews PLR (2006) Ghrelin alleviates cancer chemotherapy-associated dyspepsia in rodents. Cancer Chemother Pharmacol 58:326-333. doi:10.1007/s00280-005-0179-0
23. Wolf I, Sadetzki S, Kanety H, Kundel Y, Pariente C, Epstein N et al (2006) Adiponectin, ghrelin, and leptin in cancer cachexia in breast and colon cancer patients. Cancer 106:966-973. doi:10.1002/ cncr.21690
24. Sonis ST (2007) Pathobiology of oral mucositis: Novel insights and opportunities. J Support Oncol 5(9 Suppl 4):3-11
25. Quinn B, Potting CM, Stone R, Blijlevens NM, Fliedner M, Margulies A et al (2008) Guidelines for the assessment of oral mucositis in adult chemotherapy, radiotherapy and haematopoietic stem cell transplant patients. Eur J Cancer 44:61-72. doi:10.1016/ j.ejca.2007.09.014
26. Deichmann M, Benner A, Waldmann V, Bock M, Jäckel H, Näher H (2000) Interleukin-6 and its surrogate C-reactive protein are useful serum markers for monitoring metastasized malignant melanoma. J Exp Clin Cancer Res 19:301-307
27. Silver HJ, Dietrich MS, Murphy BA (2007) Changes in body mass, energy balance, physical function, and inflammatory state in patients with locally advanced head and neck cancer treated with concurrent chemoradiation after low-dose induction chemotherapy. Head Neck 29:893-900. doi:10.1002/hed